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Background: Optimal management of patients with lung cancer requires accurate cell typing of tumours and
staging at the time of diagnosis. Endobronchial ultrasound-guided lymph node aspiration as a method of
diagnosing and staging lung cancer is a relatively new technique.
Aim: To report the use of liquid-based-thin-layer cytology for the processing and reporting of these
specimens.
Methods: The specimens obtained from 80 patients were processed using the ThinPrep system, with the
remainder of the samples being processed as a cell block.
Results: 40 of the 81 procedures yielded malignant cells (30 non-small cell carcinoma, 8 small-cell carcinoma
and 2 combined small-cell carcinoma/non-small-cell carcinoma). The cell blocks were found to contain
sufficient material to allow the immunohistochemical characterisation of tumour cells with a range of
antibodies.
Conclusion: The use of liquid-based-thin-layer cytological techniques provides high-quality specimens for
diagnostic purposes. When used in conjunction with cell blocks, sufficient material may be obtained to allow
immunohistochemical studies to confirm the tumour cell type. Given the current move towards centralisation of
pathology services, this approach gives the pathologist high-quality specimens without the need for direct
onsite support at the time of the procedure.
O
ptimal management of patients with bronchial carci-
noma requires histological or cytological conformation
of malignancy, tumour classification and accurate
staging to allow treatment planning and the identification of
patients who will benefit from potentially curative radical
treatment.1 CT scanning is usually carried out as a first staging
procedure and can determine the presence of enlarged lymph
nodes, but the predictive value of nodal enlargement for the
presence of metastatic disease is recognised to be poor.2 3
Although recent developments such as flurodeoxyglucose
positron emission tomography, especially when combined with
CT, have shown significant improvements in the accuracy of
mediastinal staging,4 there remains a requirement to confirm
the presence of metastatic malignancy by histological or
cytological means in order to plan appropriate treatment.5
Mediastinal lymph node sampling for this purpose has been
largely carried out by mediastinoscopy or thoracoscopy,6 but
these have the disadvantage of being inpatient procedures
requiring a general anaesthetic, and in the case of mediastino-
scopy only giving access to nodes in the upper anterior
mediastinum. Transbronchial7 8 and transthoracic9 lymph node
aspiration or biopsy have previously been used to sample
mediastinal nodes, but with variable results. The development
of endoluminal ultrasound technology however, has, allowed
the development of techniques whereby lymph nodes can be
aspirated through either the airway (endobronchial ultrasound
fine-needle aspiration (EBUS–FNA)) or the oesophageal wall
(endoscopic ultrasound fine-needle aspiration (EUS–FNA)).10
We and others11–14 have previously reported the use of EBUS–
FNA in assessing patients with lung cancer. Such studies from
other centres have used standard cytological smears prepared
from the aspirated material usually, but not in all cases,12 with
the assistance of a cytologist present at the procedure. In this
paper, we report our experience of processing and reporting
EBUS–FNA specimens using liquid-based thin-layer technol-
ogy.
MATERIALS AND METHODS
Patients
During the period between May 2005 and January 2006, 81
EBUS–FNA procedures were carried out on a total of 80
patients (41 men and 39 women, aged 30–86 years) who had
been referred to the Respiratory Unit, Royal Infirmary of
Edinburgh, Edinburgh, UK. Most patients had a presumed, or
proven, diagnosis of bronchial carcinoma with hilar or
mediastinal nodal enlargement on CT scan but were not
considered to be candidates for surgical resection. To confirm
the diagnosis, establish the cell type of the tumour or confirm
the stage, EBUS–FNA was carried out as we have described
previously.11 A few patients were, however, also referred with
mediastinal lymphadenopathy of unknown cause or were
thought to have mediastinal recurrence of carcinoma.
The number of lymph node stations sampled ranged from 1–
4. In all, two or three needle passes were performed on each
node in the manner we have described previously.11 All the
samples obtained were placed directly into Cytolyt (Cytyc UK,
Crawley, West Sussex, UK) and delivered to the Pathology
Department, Royal Infirmary of Edinburgh.
Specimen processing
The specimens were processed using the T2000 ThinPrep
System (Cytyc UK, Crawley, West Sussex, UK) and the single
preparation was stained with Papanicolaou (PAP) stain. Any
remaining of the specimen was centrifuged, to form a pellet,
suspended in agar, fixed in neutral buffered formalin and
processed as a cell block from which a single H&E stained
section was cut. Further sections were cut and used for
immunohistochemical staining as required, with a range of
antibodies using standard methods and the automated staining
machines currently in use in the department.
Abbreviations: EBUS–FNA, endobronchial ultrasound fine-needle
aspiration; PAP, Papanicolaou; TTF1, thyroid transcription factor1.
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Reporting
All specimens were reported by one of three consultant
pathologists with a specific interest in thoracic pathology
(WAHW, HMM, DMS) who report both histological and
cytological specimens.
RESULTS
The aspirates obtained were of variable cellularity. Evidence of
lymph node sampling was assessed by the presence of lymphoid
cells or sheets of histiocytes often with associated pigment
consistent with the prominent sinus histiocytosis commonly
observed in mediastinal nodes. Although some aspirates were
relatively sparsely cellular, none were deemed to show evidence
of nodal sampling. In addition, all the aspirates contained
evidence of varying amounts of endobronchial-derived material
in the form of respiratory epithelial cells and alveolar
macrophages. The cell blocks again were of variable cellularity,
but many contained ‘‘mini biopsies’’ with fragments of
identifiable nodal tissue and in some cases cartilage.
From the 81 procedures carried out, metastatic malignancy
was identified in 40 cases. Non-small-cell carcinoma (fig 1) was
diagnosed in 30 cases (6 squamous carcinoma, 3 adenocarci-
noma and 21 unspecified), small-cell carcinoma (fig 2) in 8
cases and combined small-cell carcinoma/non-small-cell carci-
noma in 2 cases. In two cases of squamous carcinoma,
malignancy was diagnosed solely on the basis of the cell block,
with no identifiable tumour in the PAP-stained cytological
preparations. In addition, in one of the cases of combined
small-cell carcinoma/non-small cell carcinoma only the latter
was present in the cytological preparation and the small-cell
component was only identified in the cell block.
Immunohistochemistry with CD45, pan-cytokeratin and
CD56 was performed in sections obtained from the cell block
in the cases of small-cell carcinoma and this was found to show
patterns of staining in the tumour present similar to that seen
in more traditional histological specimens (fig 2).
Immunohistochemistry with thyroid transcription factor 1
(TTF1) and oestrogen receptor was used to evaluate cases in
which the clinical impression was of probable metastatic breast
carcinoma. In one case clinically thought to be metastatic
breast carcinoma, the cells obtained were shown to be TTF1
positive and oestrogen receptor negative, suggesting a separate
lung primary carcinoma. This finding was confirmed by
subsequent mediastinoscopy (fig 3).
The remaining 41 procedures showed no evidence of
malignancy. In one patient with unexplained lymphadeno-
pathy, discrete non-caseating granulomata were identified in
the cell block, suggesting the possibility of sarcoidosis. Further
material was subsequently submitted for histological and
cytological assessment in 11 of these patients; 7 patients
underwent mediastinoscopy, 1 had a repeat EBUS–FNA and 3
had further surgical biopsies.
The mediastinoscopies showed two cases of non-Hodgkin’s
lymphoma, two metastatic adenocarcinomas and three were
negative. Of the latter three, one had a lung biopsy and was
diagnosed with Hodgkin’s disease and another underwent
resection of a primary lung adenocarcinoma, which was found
to be node negative. The repeat EBUS–FNA performed in one
case demonstrated malignant cells consistent with a non-small-
cell carcinoma. One patient had a lung biopsy showing a high-
grade sarcoma and two other patients had biopsies of distant
metastases (brain and bone) showing non-small-cell carci-
noma.
DISCUSSION
EBUS–FNA is a relatively new technique that allows aspiration
of mediastinal and hilar lymph node groups under direct
ultrasound control.10–14 The traditional approach of making
spreads from such material may result in large numbers of
slides to screen, and assessment can be difficult if the
diagnostic material is obscured by blood. The quality of the
preparations may be improved if an appropriately trained
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Figure 1 Photomicrographs from endobronchial ultrasound fine-needle aspiration samples illustrating the appearances of metastatic adenocarcinoma (A, B)
and metaststic squamous carcinoma (C, D) in Papanicolaou-stained ThinPrep preparations and the accompanying H&E stained sections from the cell blocks.
(original magnification6400).
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Figure 2 Photomicrographs from endobronchial ultrasound fine-needle aspiration samples illustrating the appearances of metastatic small-cell carcinoma
in a Papanicolaou-stained ThipPrep preparation (A) and in a section from a cell block stained with H&E (B). Immunohistochemistry with pan-cytokeratin
shows positive staining of the tumour cells (C) whereas no staining with CD45 was identified (D; original magnification6400).
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Figure 3 Photomicrographs of specimens obtained from an endobronchial ultrasound fine-needle aspiration from a woman with a history of breast cancer
and a right hilar/paratracheal mass. Groups of malignant glandular cells consistent with origin from an adenocarcinoma were identified both in the
Papanicolaou-stained ThipPrep preparation and in the H&E-stained sections from the cell block (A). Immunistochemistry demonstrated that the tumour cells
expressed BerEp4 (B) and showed focal nuclear staining with thyroid transcription factor1 (C). No staining with antibodies to oestrogen receptor was
identified (D). A subsequent mediastinoscopy confirmed the presence of adenocarcinoma, which was morphologically different from the breast lesion and
consistent with origin from a bronchial carcinoma, (original magnification 6400).
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cytologist or cytology technician is present at the procedure.14
This also has the advantage that the quality of the aspirates can
be assessed at the time. Provision of such support is, however,
expensive and may be difficult to provide given the current
trends to centralise pathology services with increasing sub-
specialisation. We have previously introduced liquid-based
cytology techniques for processing bronchial cytology speci-
mens where similar issues of specimen quality apply. In our
experience, the approach we describe provides samples that are
relatively straightforward to report. The cells are well visualised,
not obscured by blood and air-drying artefacts are avoided.
Although lymph node FNA provides a reliable way of detecting
the presence of malignancy and will often permit cell typing,13 it is
often difficult to determine the most likely primary site when
there are conflicting clinical possibilities. The use of cell blocks
and immunohistochemistry may give some useful information,
and in some cases we were able to address the issue by
demonstrating TTF1 staining of the tumour cells but in other
cases we were unable to make any comment owing to either the
sparsity of the material or the absence of staining with any of the
tissue-specific markers. This suggests that case selection for
EBUS–FNA is important, and that although it is a valuable tool in
staging lung cancer, more complex cases where treatment options
are determined by the probable primary site of the tumour rather
than simply by the presence or absence of malignancy then
lymph node biopsy by mediastinoscopy may be more appropriate.
In our experience to date, we have not identified evidence of
lymphoma in three cases where this turned out to be the final
diagnosis (two cases of non-Hodgkin’s lymphoma and one case
of Hodgkin’s lymphoma diagnosed on mediastinoscopy and
lung biopsy, respectively). On review, no specific cytological
features were seen to suggest the diagnoses. This may suggest
that diagnostic material was not obtained in at least the two
cases with subsequent positive mediastinoscopies. The potential
role of EBUS–FNA cytology in the diagnosis of lymphoma
remains controversial and although ancilliary studies such as
flow cytometry and molecular studies may play a role,
histological assessment and classification remains the ‘‘gold
standard’’ for planning treatment schedules. Although we did
identify one case where there was evidence of a granulomatous
process in the material within the cell block from an aspirated
node, the technique should not, in our view, be regarded as a
reliable method to assess the aetiology of isolated lympadeno-
pathy when lymphoma and sarcoidosis are the principal clinical
differential diagnoses.
As with many cytological samples, a positive result is helpful
in patient management but the significance of a negative one is
less certain. In our series, most patients with negative aspirates
did not undergo mediastinoscopy as they were not considered
surgical candidates, and subsequent treatment was guided by
the clinical and radiological characteristics of the case.
Nevertheless, we would conclude from our experience that
the use of liquid-based thin-layer cytological techniques for
EBUS–FNA samples provides good-quality specimens for
diagnostic purposes and that the use of cell blocks provides
additional material for assessment and immunohistochemical
staining when this is required.
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Take-home messages
N Endobronchial ultrasound fine-needle aspiration is a
useful tool for the diagnosis and staging of lung cancer.
N The use of thin-layer cytological techniques provides
good-quality specimens for diagnostic purposes.
N The routine use of cell blocks adds to the diagnostic yield
and provides material for immunohistochemical studies.
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